| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 247.443.159 $ | +157.338.283 $ | +206,4 % | 18 | 73.784.497 $ | +73.784.497 $ | 7 | |||||
| Morse Asset Management, Inc | → 0 | 39.154.842 $ | +12.591.258 $ | +47,4 % | 1 | 26.563.584 $ | +26.563.584 $ | 1 | |||
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 30.750.658 $ | +15.859.298 $ | +106,5 % | 1 | 14.891.360 $ | +14.891.360 $ | 1 | |
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 22.440.470 $ | +20.554.229 $ | +1.089,7 % | 1 | ||||
| Relay Therapeutics, Inc. | RLAY | → 0 | Neutral | 17.938.994 $ | +10.312.668 $ | +135,2 % | 1 | 7.626.326 $ | +7.626.326 $ | 1 | |
| Sionna Therapeutics, Inc. | SION | → 0 | Neutral | 15.801.232 $ | +7.693.690 $ | +94,9 % | 1 | 8.107.542 $ | +8.107.542 $ | 1 | |
| Veradermics, Inc | MANE | → 0 | Neutral | 15.697.448 $ | +15.697.448 $ | 1 | |||||
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Stark | 11.887.204 $ | +11.887.204 $ | 1 | |||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 11.627.204 $ | +8.034.742 $ | +223,7 % | 1 | ||||
| Pharvaris N.V. | PHVS | → 0 | Sehr stark | 11.230.618 $ | +5.714.695 $ | +103,6 % | 1 | 5.515.923 $ | +5.515.923 $ | 1 | |
| Inhibikase Therapeutics, Inc. | IKT | → 0 | Neutral | 10.910.756 $ | +7.323.256 $ | +204,1 % | 1 | ||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 9.349.784 $ | +3.925.897 $ | +72,4 % | 1 | 5.423.887 $ | +5.423.887 $ | 1 | |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 9.065.794 $ | +3.409.919 $ | +60,3 % | 1 | 5.655.875 $ | +5.655.875 $ | 1 | |
| uniQure N.V. | QURE | → 0 | Schwach | 8.220.960 $ | +8.220.960 $ | 1 | |||||
| LeonaBio, Inc. | LONA | → 0 | 8.094.492 $ | +5.114.175 $ | +171,6 % | 1 | |||||
| Damora Therapeutics, Inc. | GLTO | → 0 | 7.200.200 $ | +7.200.200 $ | 1 | ||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Sehr schwach | 6.551.364 $ | +4.235.190 $ | +182,9 % | 1 | ||||
| Gossamer Bio, Inc. | GOSS | → 0 | Schwach | 5.817.121 $ | +5.817.121 $ | 1 | |||||
| Tyra Biosciences, Inc. | TYRA | → 0 | Neutral | 5.704.018 $ | +3.746.333 $ | +191,4 % | 1 | ||||
| 247.443.159 $ | +157.338.283 $ | +206,4 % | 18 | 73.784.497 $ | +73.784.497 $ | 7 | |||||